Get all the latest information from the CURE Educated Patient® Prostate Cancer Summit report!
December 11th 2022, 4:00pm
Watch Dr. Douglas A. Tremblay, from Mount Sinai, discuss treatment for essential thrombocythemia during the CURE Educated Patient MPN Summit.
December 10th 2022, 8:00pm
Watch Dr. Aaron T. Gerds, from Cleveland Clinic Taussig Cancer Institute, discuss essential thrombocythemia risk during the CURE Educated Patient MPN Summit.
June 17th 2022, 1:00pm
Watch Dr. Jeremie Calais, Dr. Tian Zhang, Dr. Landon C. Brown and Jim Rosenfield answer questions about novel agents and strategies during the CURE Educated Patient Prostate Cancer Summit.
June 16th 2022, 1:00pm
Watch Dr. Landon C. Brown, from Atrium Health Levine Cancer Institute, discuss approaches to hormone therapy, during the CURE Educated Patient Prostate Cancer Summit.
June 15th 2022, 1:00pm
Watch Dr. Tian Zhang, from UT Southwestern Medical Center, discuss novel agents, during the CURE Educated Patient Prostate Cancer Summit.
June 14th 2022, 1:00pm
Watch Dr. Jeremie Calais, from UCLA, discuss novel imaging strategies, during the CURE Educated Patient Prostate Cancer Summit.
June 13th 2022, 1:00pm
Watch Dr. Veda N. Giri, Dr. Umang Swami and Sue Friedman answer questions about genetics and genomics during the CURE Educated Patient Prostate Cancer Summit.
June 12th 2022, 2:00pm
Watch Dr. Umang Swami, from Huntsman Cancer Institute, discuss genomic changes and PARP inhibitors, during the CURE Educated Patient Prostate Cancer Summit.
June 11th 2022, 2:00pm
Watch Dr. Veda N. Giri, from Sidney Kimmel Cancer Center at Thomas Jefferson University, discuss genetic testing and who should get it, during the CURE Educated Patient Prostate Cancer Summit.
June 10th 2022, 1:00pm
Watch Dr. Ganesh Raj, Dr. Andrew Z. Wang, and Bruce Williams, discuss treatment for localized disease, during the CURE Educated Patient Prostate Cancer Summit.
Cancer Survivors Can Get Tired of Being Called ‘Strong’
‘Key Signs’ of Cytokine Release Syndrome to Know
FDA Grants Fast Track Designation to CTX-009 in Biliary Tract Cancer
A Cancer Drug that Impacted My Life for SLL